Home › Colorectal Cancer › Ohio › Cleveland
Pag-aaral pangklinika para sa Colorectal Cancer sa Cleveland, OH
24 pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cleveland (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Louis Stokes Cleveland VA Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Nagre-recruitPhase 3
- University Hospital of Cleveland, Cleveland
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Nagre-recruitPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
- Taussig Cancer Insititute Cleveland Clinic, Cleveland
- at 2 pa
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Case Comprehensive Cancer Center, Cleveland
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Nagre-recruit
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Nagre-recruitPhase 1
- Cleveland Clinic Foundation, Cleveland
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Clinical Study Site, Cleveland
- Clinical Study Site, Cleveland
- Clinical Study Site, Mayfield Heights · 12 mi ang layo
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Nagre-recruitPhase 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Nagre-recruitPhase 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1
- Cleveland Clinic, Taussig Cancer Institute, Cleveland
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Nagre-recruitObservasyonal na pag-aaral
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Cleveland Clinic, Cleveland
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Nagre-recruitPhase 1/2
- Cleveland Clinic Foundation, Cleveland
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Nagre-recruitPhase 1
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Cleveland
- Non-Small Cell Lung Cancer43 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Kanser sa Suso35 pag-aaral
- Kanser sa Prostate34 pag-aaral
- Pagkabigo ng Puso33 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Kanser sa Baga26 pag-aaral
- Sakit sa Puso at Ugat ng Dugo22 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Crohn's Disease19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.